Schultz Jel J, Glascock BJ, Witt SA, et al. Accelerated onset of heart failure in mice during pressure overload with chronically decreased
[4]
Kaneda R, Takada S, Yamashita Y, et al. Genome-wide histone methylation profile for heart failure. Genes Cells, 2009, 14(1):69-77.
[5]
Zorio E, Medina P, Rueda J, et al. Insights into the role of microRNAs in cardiac diseases: from biological signalling to therapeutic targets. Cardiovasc Hematol Agents Med Chem, 2009, 7(1):82-90.
[8]
Antequera F, Bird A. Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci U S A, 1993, 90(24):11995-11999.
[13]
Inesi G, Prasad AM, Pilankatta R. The Ca2+ ATPase of cardiac sarcoplasmic reticulum: Physiological role and relevance to diseases. Biochem Biophys Res Commun, 2008, 369(1):182-187.
[17]
Rodríguez-Reyna TS, Arrieta O, Castillo-Martínez L, et al. Tumour Necrosis Factor alpha and Troponin T as predictors of poor prognosis in patients with stable heart failure. Clin Invest Med, 2005, 28(1):23-29.
[18]
Kubota T, Bounoutas GS, Miyagishima M, et al. Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy. Circulation, 2000, 101(21):2518-2525.
[1]
Dong C, Yoon W, Goldschmidt-Clermont PJ. DNA methylation and atherosclerosis. J Nutr, 2002, 132(8 Suppl):2406S-2409S.
[2]
Alikhani-Koopaei R, Fouladkou F, Frey FJ, et al. Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression. J Clin Invest, 2004, 114(8):1146-1157.
[3]
Bush EW, McKinsey TA. Targeting histone deacetylases for heart failure. Expert Opin Ther Targets, 2009, 13(7):767-784.
[6]
Barringhaus KG, Zamore PD. MicroRNAs: regulating a change of heart. Circulation, 2009, 119(16):2217-2224.
[10]
Fraga MF, Ballestar E, Paz MF, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A, 2005, 102(30):10604-10609.
[11]
Periasamy M, Huke S. SERCA pump level is a critical determinant of Ca(2+) homeostasis and cardiac contractility. J Mol Cell Cardiol, 2001, 33(6):1053-1063.
[12]
Zarain-Herzberg A, Afzal N, Elimban V, et al. Decreased expression of cardiac sarcoplasmic reticulum Ca(2+)-pump ATPase in congestive heart failure due to myocardial infarction. Mol Cell Biochem, Mol Cell Biochem, 1996, 163-164:285-290.
Candia AM, Villacorta H Jr, Mesquita ET. Immune-inflammatory activation in heart failure. Arq Bras Cardiol, 2007, 89(3):183-190, 201-208.
[19]
Lee SH, Chen YC, Chen YJ, et al. Tumor necrosis factor-alpha alters calcium handling and increases arrhythmogenesis of pulmonary vein cardiomyocytes. Life Sci, 2007, 80(19):1806-1815.
[20]
Kao YH, Chen YC, Chen CC, et al. Tumor necrosis factor-alpha decreases sarcoplasmic reticulum Ca2+-ATPase expressions via the promoter methylation in cardiomyocytes. Crit Care Med, 2010, 38(1): 217-222.
[21]
Movassagh M, Choy MK, Goddard M, et al. Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure. PLoS One, 2010, 5(1):e8564.